Timothy Williams - 15 Dec 2022 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role: SVP & General Counsel
Signature: /s/ Timothy Williams
Issuer symbol: VNDA
Transactions as of: 15 Dec 2022
Net transactions value: -$56,070
Form type: 4
Filing time: 16 Dec 2022, 15:38:12 UTC
Previous filing: 17 Aug 2022
Next filing: 21 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNDA	Common Stock	Sale	$56,070	-8,000	-8.4%	$7.01	87,551	15 Dec 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.946 to $7.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.946 to $7.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.